Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Age
12–30
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects who have completed study A1481156 and are judged by the Investigator to derive clinical benefit from continuous treatment with sildenafil citrate therapy.
Subjects with pulmonary arterial hypertension (PAH ) being treated at a study site in India
Subjects who are willing and able to comply with scheduled visits, treatment plan, and other study procedures
You may not be if
Pregnant or lactating female subjects.
Current participation in other studies and during study participation, except for the A1481304 follow-up period.
Other severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with study participation or investigational product administration and, in the judgment of the investigator, would make the subject inappropriate for entry into this study.
Clareo Health | An Open Label Access Study For Subjects Who Completed A1481156
